Skip to main content
OpenTrials
Completed

NCT Number: NCT00373178

Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

AHEPA University Hospital of Thessaloniki, Thessaloniki, Greece

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Recently diagnosed type 2 diabetes
  • No previous anti-diabetic medications

Exclusion criteria

  • Heart failure
  • Renal disease
  • Liver disease
  • Life-threatening diseases

Treatment and study plan

rosiglitazone

Drug

metformin

Drug

Anti-diabetic medications

Drug

Primary outcomes

  1. Novel cardiovascular risk factors modification

    Time frame: 2 years

Secondary outcomes

  1. Lipid and glucose regulation

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Aristotle University Of Thessaloniki

Other

Collaborators

  • University of Athens

Registry information

Important dates

Study start
2005
Primary completion
2007
Study completion
2008
First posted
Sep 7, 2006
Registry last updated
Nov 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.